|
Model Number AP06016B5 |
Device Problem
No Apparent Adverse Event (3189)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 02/01/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Conclusion not yet available, evaluation in process.A follow-up report will be submitted as soon as the investigation is complete.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
|
|
Event Description
|
The user has several complaints about the oscor adelante 6f introducer kits and wished to express her dissatisfaction.The implanting physician explained that these introducer kits allow bleeding when the lead is inserted even though they are labeled as 6f, they seem to have a larger inner diameter.Furthermore, the implanter finds that the introducers are "sticky" and expresses difficulty when trying to double wire when gaining access to the vein.This is also an issue when they try to reposition the lead while it is still in the sheath, she explained that it is very difficult to pull back on the lead as it sticks to the inner lumen of the sheath.Finally, when using passive leads, if the lead needs to be repositioned and removed from the patient, she is finding that the tines are getting stuck on the tip of the introducer, and she is not able to pull it back through.What this means is that she is having to split the sheath and find venous access again.Not only is this frustrating but it lengthens the case which increases the risk of infection, fluoroscopy exposure and pneumothorax.The procedure was successful.Patient was not subject to procedures which might have damaged this device.Event took place during the implantation procedure.The event did not cause patient adverse event.The device was discarded.The implanting physician did not believe that there was a deficiency with the product but was rather expressing her dissatisfaction with the products design.This report is for administrative purposes only.
|
|
Manufacturer Narrative
|
The following sections were updated in follow-up 1.B4, g3, g6, h2, h6 & h10.No product was returned to oscor inc.For evaluation; however, a complaint notification was provided.Without the return of the actual device in question for evaluation, oscor inc.Is unable to determine the exact cause for this incident.A review of the manufacturing processes indicates the production operators are instructed to 100% visually inspect for any obvious defect prior to shipment.At this time, it is not possible to assign a definitive root cause for the event as reported.The complaint is non-verifiable as the product was not returned for evaluation.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
|
|
Search Alerts/Recalls
|
|
|